Please login to the form below

Not currently logged in
Email:
Password:

UK biotech body the BIA appoints Steve Bates as CEO

The former APCO director has experience in biotech with Genzyme and government as Labour adviser

Steve Bates - BIA BioIndustry AssociationThe UK's BioIndustry Association (BIA) has named the director of public affairs firm APCO Steve Bates (pictured) as its new CEO.

He will take up his new role on July 2 and replace Glyn Edwards, who has the led the bioscience trade body on an interim basis since November, 2011.

Bates had only been in his present role at APCO since the beginning of the year having previously served at Genzyme as its senior director external affairs and market access, Commonwealth and Ireland from March 2010 to January 2012.

During this time, he worked on the establishment of the government's Office for Life Science and was a member of the BIA's Communications Advisory Committee.

He initially joined biotech Genzyme in 2008 to serve as government relations director for the UK and Ireland.

This move followed several years spent working as special adviser to the UK's Labour government when it was in power. Bates' time working for Labour included advising John Reid when he was the country's Health Secretary.

“We are delighted that Steve is joining the BIA,” said BIA chair Tim Edwards. “I am certain that his experience in the bioscience sector and within government will prove to be invaluable.”

Part of Bates' remit will be to campaign for the introduction of the BIA's much-championed Citizens Innovation Fund, which would allow individuals make a tax-free investment of up to £15,000 a year in innovative businesses.

“UK bioscience is at the heart of the new global economy,” said Bates. “The sector's talented and visionary researchers, developers and executives are producing the treatments and innovations to help patients in the future.

“Having worked both in government and biotech I know how to be an effective voice for the sector and look forward to working in partnership with government, academia and the health service to enable bioscience companies in the UK to succeed.”

26th June 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Study Report

Market Study Report is a hub for market intelligence products and services. We streamline the purchase of your market research...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics